Incontinence-associated dermatitis (IAD)
The management of incontinence-associated dermatitis is important in caring for incontinent patients. The lack of comparability of clinical trial outcomes is a major challenge in the field of evidence-based incontinence-associated dermatitis prevention and treatment. Core outcome sets may therefore be helpful to improve the value of clinical incontinence-associated dermatitis research.
Scope of the intended COS
- Study types: Intervention studies such as RCTs
- Global scope
Systematic literature reviews, patient interviews and consensus study using Delphi procedures.
Involvement of stakeholders
During the domain identification patients and industry representatives were involved.
The following five core outcome domains have been identified: erythema, erosion, maceration, incontinence-associated dermatitis-related pain and patient satisfaction. Currently work is in progress to identify outcome measurement instruments per domain.
The work is funded by the Skin Integrity Research Group (Belgium) and the clinical Research for Hair and Skin Science (Germany)
Belgium, Germany and many more during the Delphi study
Date of updates
- Prof. Dr. Dimitri Beeckman
- Dr. Jan Kottner
Project team members
- Dorien de Meyer
- Karen Van den Bussche
- Sabrina Gabriel
Responsible member of Methods group (as assigned by CS-COUSIN)
- Prof. Dr. Phyllis Spuls
Prof. Dr. Dimitri Beeckman
Skin Integrity Research Group
University Centre for Nursing and Midwifery
GHENT UNIVERSITY, Department of Public Health and Primary Care,
Dr. Jan Kottner
Charité – Universitätsmedizin Berlin
Department of Dermatology and Allergy
Clinical Research Center for Hair and Skin Science
1. De Meyer D, Gabriel S, Kottner J, Van Damme N, Van Den Bussche K, Verhaeghe S, Van Hecke A, Beeckman D. Outcome measurement instruments for erythema associated with incontinence-associated dermatitis: systematic review. J Adv Nurs. 2019.
2. De Meyer D, Kottner J, Beele H, Schmitt J, Lange T, Van Hecke A, Verhaeghe S, Beeckman D. Delphi procedure in core outcome set development: rating scale and consensus criteria determined outcome selection. J Clin Epidemiol. 2019;111:23-31.
3. Kottner J, Beeckman D. Core Outcome Sets (COS) for clinical trials in health- and nursing science: the case of Incontinence-Associated Dermatitis (IAD). J Adv Nurs. 2017;73(10):2268-2269.
4. Ronsch H, Apfelbacher C, Brans R, Matterne U, Molin S, Ofenloch R, Oosterhaven JAF, Schuttelaar MLA, Weisshaar E, Yew YW, Bauer A. Which outcomes have been measured in hand eczema trials? A systematic review. Contact Dermatitis. 2019;80(4):201-207.
5. Van den Bussche K, De Meyer D, Van Damme N, Kottner J, Beeckman D. CONSIDER - Core Outcome Set in IAD Research: study protocol for establishing a core set of outcomes and measurements in incontinence-associated dermatitis research. J Adv Nurs. 2017;73(10):2473-2483.
6. Van den Bussche K, Kottner J, Beele H, De Meyer D, Dunk AM, Ersser S, Lange T, Petrovic M, Schoonhoven L, Smet S, Van Damme N, Verhaeghe S, Van Hecke A, Beeckman D. Core outcome domains in incontinence-associated dermatitis research. J Adv Nurs. 2018;74(7):1605-1617.